Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow
NCT00675181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2012-09-11
Summary
Does melatonin affect basal metabolic rate, increase choroidal blood flow and reduce the vasospastic syndrome (VS)?
The main questions are:
Do women with VS exhibit...
* a different basal metabolic rate
* a reduced choroidal blood flow
* a reduced increase of oxygen consumption after intake of ice-water
* a different oxygen consumption after melatonin intake
* a different choroidal blood flow after melatonin intake
* a different oxygen consumption after melatonin intake and after intake of ice-water….?
Conditions
- Vasospastic Syndrome
Interventions
- DRUG
-
per os
- DRUG
-
Melatonin
5mg per os
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Selim Orguel, MD · University Eye Clinic, Basel, Switzerland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Effect of Total Sleep Deprivation on Vascular Function
NCT04535219 ·Status: COMPLETED ·Phase: NA
-
Correlation Between Melatonin Levels in Different Biological Fluids
NCT05784090 ·Status: UNKNOWN
-
Sleep and Cardiovascular Health in Adolescence
NCT03727906 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
NCT05371483 ·Status: ENROLLING_BY_INVITATION
-
Melatonin and Cardiac Outcome After Major Surgery
NCT00315926 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude
NCT03588676 ·Status: COMPLETED ·Phase: NA
-
Color-dependent Melatonin Suppression
NCT02936674 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
NCT01586039 ·Status: COMPLETED ·Phase: NA
-
Effects of Sleep Deprivation on Diaphragm Command During an Inspiratory Endurance Trial in Healthy Volunteers.
NCT02725190 ·Status: COMPLETED ·Phase: NA
-
Circadian Melatonin Rhythms in Critically Ill Patients With Delirium
NCT04721613 ·Status: COMPLETED
-
Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)
NCT00282061 ·Status: UNKNOWN ·Phase: PHASE1
-
Cardiometabolic Outcomes With Light Exposure During Sleep
NCT05317559 ·Status: COMPLETED ·Phase: NA
-
Determinants of Age Related Breathing Instability During Non-Rapid-Eye-Movement (NREM) Sleep
NCT00732199 ·Status: COMPLETED ·Phase: NA
-
The Influence of Sleep on Cardiovascular Outcomes
NCT06535178 ·Status: RECRUITING ·Phase: NA
-
Effects of Afternoon and Evening Light on Teenagers' Melatonin Levels, Alertness, Sleepiness and Sleep
NCT05483296 ·Status: COMPLETED ·Phase: NA
-
Enhancing Slow Wave Sleep With Sodium Oxybate
NCT00506974 ·Status: COMPLETED ·Phase: PHASE4
-
Physiologic Effects of Sleep Restriction
NCT01433315 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Partial Sleep Deprivation
NCT00669513 ·Status: COMPLETED ·Phase: PHASE3
-
Circadian Rhythm of Melatonin in Burns
NCT01596101 ·Status: COMPLETED
-
Inorganic Nitrate and OSA
NCT03930563 ·Status: COMPLETED ·Phase: NA
-
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
NCT03255408 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
NCT06380491 ·Status: RECRUITING ·Phase: PHASE4
-
Beneficial Effects of Daytime Light Exposure and Physical Activity on the Human Circadian Clock and Sleep
NCT05513547 ·Status: COMPLETED ·Phase: NA
-
Effects of Vitamin B12 on the Body's Internal Clock
NCT00120484 ·Status: COMPLETED ·Phase: NA
-
Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
NCT02063217 ·Status: COMPLETED ·Phase: NA